Limoges, France

Franck Sturtz

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: I.ceram, Université De Limoges. Active years: 2022-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Franck Sturtz: Innovator in Porous Composition Technology

Introduction

Franck Sturtz is a notable inventor based in Limoges, France. He has made significant contributions to the field of medical technology, particularly in the treatment of bone cancers. His innovative approach has led to the development of a unique patent that addresses critical health challenges.

Latest Patents

Sturtz holds a patent for a "Porous composition filled with an active ingredient." This invention relates to a composition designed for the release of an active ingredient, which includes a porous matrix, a filled carrier within the matrix, and the active ingredient itself. This technology is particularly suitable for the treatment of bone cancers, showcasing Sturtz's commitment to advancing medical solutions.

Career Highlights

Throughout his career, Franck Sturtz has worked with prominent organizations, including I.Ceram and Université de Limoges. His experience in these institutions has allowed him to refine his expertise and contribute to groundbreaking research and development in his field.

Collaborations

Sturtz has collaborated with notable colleagues such as François Bertin and Eric Denes. These partnerships have further enriched his work and expanded the impact of his innovations.

Conclusion

Franck Sturtz is a distinguished inventor whose work in porous composition technology has the potential to transform the treatment of bone cancers. His dedication to innovation and collaboration continues to inspire advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…